LKL International Bhd (-ve)
TRADING of shares in LKL International Bhd (fundamental: 1.4/3, valuation: 0.3/3) triggered our proprietary momentum algorithm yesterday for the first time this year.
The stock closed unchanged at 15 sen, with a market capitalisation of RM64.32 million.
A total of 670,000 shares were done versus its 200-day average trading volume of 242,788 shares.
The company is principally involved in the design and manufacturing of medical and healthcare beds peripherals and accessories.
Last week, LKL, through its subsidiary LKL Advance Metaltech Sdn Bhd, inked a collaborative memorandum of understanding (MoU) with FKS Medical Care Sdn Bhd to cooperate in the market development of Sanuwave Health Inc’s dermaPACE, an advanced medical device used to treat acute and chronic wounds.
Under the two-year MoU, LKL said FKS will be responsible for introducing dermaPACE into Malaysia, and both FKS and LKL Advance Metaltech will cooperate together to promote and market the device in the country.